OakChart

Tenon Medical Inc

TNONHealthcare·Medical Devices·USA·Nano·NASD·Nov 11 • 3:59 PM ET

1.75+0.00 (0.29%)
2026-11-12 02:30 CET
Market cap
4.68 USD m
Revenue, TTM
5.31 USD m
Net income, TTM
-13.70 USD m
Free cash flow, TTM
-12.82 USD m
EPS diluted, TTM
-47.46
P/E
-
Compare

Price

TNON against its 20, 50 and 200-day averages
2050200beatmissearnings
0.0010.0020.0030.0063.6M127.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26TNONclose 1.7520-day 2.1350-day 3.10200-day 15.821.75

96.2% under the 52-week high of 45.50 on 12 Nov 2025. 52-week low 1.57 on 6 Nov 2026. Last 15 sessions, 57.9% high to low

Volume 0.01× normal · the line is the 50-bar volume average

Profile

TNON
52-week range, 0% of the way up
1.5745.50

Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company was founded by Richard Ferrari and Richard Ginn on June 19, 2012 and is headquartered in Los Gatos, CA.

Employees26
IPOApr 27, 2022
Beta1.43
ATR, 14d0.30
Rel volume0.01
Short float3.85%
Insider own8.38%
Inst own0.61%

Snapshot

6 groups

Valuation

Index-
Market Cap4.69M
Enterprise Value12.23M
Income-13.70M
Sales5.31M
Book/sh-14.57
Cash/sh0.62
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees26
IPOApr 27, 2022

Ratios

P/E-
Forward P/E-
PEG-
P/S0.88
P/B-
P/C2.79
P/FCF-
EV/EBITDA-
EV/Sales2.30
Quick Ratio0.48
Current Ratio0.58
Debt/Eq-
LT Debt/Eq-
Option/ShortNo / Yes

Earnings

EPS (ttm)-47.46
EPS next Y-4.87
EPS next Q-4.22
EPS this Y64.29%
EPS next Y77.08%
EPS next 5Y71.34%
EPS past 3/5Y79.20% 16.41%
Sales past 3/5Y78.71% 145.95%
EPS Y/Y TTM77.34%
Sales Y/Y TTM80.25%
EPS Q/Q3.29%
Sales Q/Q126.77%
EarningsNov 12 AMC
EPS/Sales Surpr.-47.02% -16.95%

Ownership

Insider Own8.38%
Insider Trans-2.87%
Inst Own0.61%
Inst Trans0.50%
ROA-130.22%
ROE-551.19%
ROIC-
Gross Margin66.81%
Oper. Margin-228.03%
Profit Margin-257.85%
SMA20-18.19%
SMA50-43.66%
SMA200-88.97%
Trades-

Technical

Shs Outstand2.69M
Shs Float2.46M
Short Float3.85%
Short Ratio0.01
Short Interest0.09M
52W High45.50 -96.16%
52W Low1.57 11.15%
Volatility10.49% 8.57%
ATR (14)0.30
RSI (14)32.16
Beta1.43
Rel Volume0.01
Avg Volume6.34M
Volume67,387

Performance

Perf Week-8.64%
Perf Month-39.62%
Perf Quarter-70.72%
Perf Half Y-93.08%
Perf YTD-94.76%
Perf Year-95.85%
Perf 3Y-99.74%
Perf 5Y-
Perf 10Y-
Recom1.00
Target Price10.50
Prev Close1.74
Price1.75
Change %0.29%

Peers

Mkt cap
TickerCompanyMkt cap
SIBNSI-BONE Inc1.13B
XTNTXtant Medical Holdings Inc38.99M
SINTSINTX Technologies Inc12.25M
ATECAlphatec Holdings Inc1.14B
OFIXOrthofix Medical Inc292.66M
NMTCNeuroOne Medical Technologies Corp7.31M
SIShoulder Innovations Inc458.62M
TMCITreace Medical Concepts Inc331.73M
GMEDGlobus Medical Inc9.99B
CARLCarlsmed Inc507.83M

Insider trading

latest 14 of 31
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
HRT FINANCIAL LP10% OwnerSep 10 '26Buy3.6367,925246,29715,839Sep 11 02:13 PM
HRT FINANCIAL LP10% OwnerSep 09 '26Buy3.4039,508134,32718,182Sep 11 02:13 PM
HRT FINANCIAL LP10% OwnerSep 08 '26Buy3.347072,3612,653Sep 11 02:13 PM
HRT FINANCIAL LP10% OwnerSep 10 '26Sale5.5665,582364,63615,839Sep 11 02:13 PM
HRT FINANCIAL LP10% OwnerSep 09 '26Sale2.8860,343174,00918,182Sep 11 02:13 PM
Williamson KevinChief Financial OfficerSep 08 '26Option Exercise0.003002,591Sep 10 04:01 PM
HRT FINANCIAL LP10% OwnerSep 03 '26Buy3.981,6586,5993,452Sep 08 01:27 PM
HRT FINANCIAL LP10% OwnerSep 04 '26Sale3.701,5065,5721,946Sep 08 01:27 PM
HRT FINANCIAL LP10% OwnerSep 01 '26Buy4.571,7908,1802,244Sep 03 04:58 PM
HRT FINANCIAL LP10% OwnerSep 02 '26Sale4.534502,0381,794Sep 03 04:58 PM
HRT FINANCIAL LP10% OwnerAug 28 '26Buy5.5818,357102,4581,730Sep 01 04:46 PM
HRT FINANCIAL LP10% OwnerAug 28 '26Sale7.327,02351,3881,730Sep 01 04:46 PM
HRT FINANCIAL LP10% OwnerAug 31 '26Sale4.661,2765,946454Sep 01 04:46 PM
HRT FINANCIAL LP10% OwnerAug 27 '26Sale4.964192,0789,604Aug 31 03:12 PM

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 198
  • Tenon Medical, Inc. Sets Date for Third Quarter 2026 Earnings (ACCESSWIRE)
  • Tenon Medical(R) Announces Completion of Initial Alpha Cases of the New Quickstep(TM) Decorticator for the Next-Generation SImmetry(R)+ SI Joint Fusion System (ACCESSWIRE) +5.61%
  • Tenon Medical(R) Adds Eight New Patents Issued by the United States Patent and Trademark Office Through Q3 2026 (ACCESSWIRE)
  • Tenon(R) Medical Announces Full Commercial Launch of the SImmetry(R)+ SI Joint Fusion 3D Printed Lateral Screw Following Successful Alpha Launch (ACCESSWIRE) +49.82%
  • WallachBeth Capital Announces Closing of Tenon Medical Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338 (PR Newswire) -6.24%
  • Tenon Medical Announces Closing of Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338 (ACCESSWIRE)
  • WallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338 (PR Newswire) +11.89%
  • Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338 (ACCESSWIRE)
  • Tenon Medical Announces Early Repayment of Its Convertible Notes (ACCESSWIRE) -27.38%
  • WallachBeth Capital Announces Closing of Tenon Medical (PR Newswire) -9.40%
  • Tenon Medical Announces Closing of $3M Private Placement Offering (ACCESSWIRE)
  • WallachBeth Capital Announces Tenon Medical Pricing of $3M Private Placement Offering (PR Newswire)
  • Tenon Medical Announces Pricing of $3M Private Placement Offering (ACCESSWIRE)
  • Tenon Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement (ACCESSWIRE) -7.61%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-12--4.225--1.552
2026Q22026-08-13-12.350-8.400-12.3501.281.542
2026Q12026-05-12-10.850-10.675-10.7971.381.302
2025Q42026-03-19-10.150-12.600-10.1501.501.382
2025Q32025-11-13-14.000-12.950-14.1661.171.122
2025Q22025-08-13-12.600-16.450-12.7670.560.912
2025Q12025-05-13-35.350-34.650-35.1850.730.782
2024Q42025-03-20368.55-131.95-34.4230.800.901
2024Q32024-11-13-127.05-215.6-127.070.891.261
2024Q22024-08-13-285.6-303.8-285.750.900.952
2024Q12024-05-14-350-375.2-350.960.720.782
2023Q42024-03-12131.6-386.4-337.470.810.992
2023Q32023-11-14-408.8-784-4,0990.941.072
2023Q22023-08-08-924-1,064-919.320.740.931
2023Q12023-05-09-1,204-1,036-1,2030.430.461
2022Q42023-03-09-1,960-2,268-1,9700.280.421

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2022FY-6,608-7,084-6,6140.690.83
2023FY-2,405-2,723-2,4052.933.05
2024FY-394.1-753.55-394.23.283.41
2025FY-59.500-63.525-59.5003.943.84
2026FY--21.250--6.02
2027FY--4.870--8.87
2028FY--1.400--18.11
2029FY--0.600--26.21
2030FY-0.600--37.73

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-282011.551.431.68
2026Q3S2026-10-232021.551.431.68
2026Q3S2026-08-211011.431.431.43
2026Q3S2026-08-142011.651.431.87
2026Q3S2026-08-132001.731.601.87
2026Q3S2026-07-272001.731.601.87
2026Q3S2026-06-032101.731.601.87
2026Q3S2026-05-132111.731.601.87
2026Q3S2026-03-202011.671.471.87
2026Q3S2026-01-282001.731.471.98
2026Q3S2025-11-142101.731.471.98
2026Q3S2025-11-111001.191.191.19
2026Q3S2025-11-101001.191.191.19
2026Q3S2025-11-091001.191.191.19

Estimate history

EPS, annual-126.98-145.824-1756.328-6614.328-2405.007-394.197-59.515-47.4597
Period2019202020212022202320242025TTM
EPS, quarterly-285.751-127.07-34.423-35.185-12.767-14.166-10.15-10.797-12.347
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual0.0540.0440.160.6912.9283.2773.9445.31
Period2019202020212022202320242025TTM
Sales, quarterly0.9010.8870.770.7260.5641.1731.4811.3791.279
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0.0040.0040.0040.0040.0090.090.310.331
Period2019202020212022202320242025MRQ
Shares, quarterly0.0140.090.090.2170.2170.2460.310.3230.331
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue5.313.943.282.930.690.160.040.05
Cost of Goods Sold Incl. D&A1.761.591.572.111.620.170.020.02
Gross Profit3.552.361.710.81-0.93-0.010.030.04
Selling, General and Administrative Excl. Other15.6614.3715.4816.5417.806.450.560.57
Research and Development2.382.152.603.162.831.720.220.37
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-12.11-12.01-13.77-15.73-18.73-6.46-0.54-0.53
Interest Expense1.030.000.030.020.350.620.170.05
Unusual Expense0.780.780.000.000.000.000.000.00
Net Income Before Taxes-13.70-12.56-13.67-15.58-18.92-7.08-0.71-0.59
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-13.70-12.56-13.67-15.58-18.92-7.08-0.71-0.59
Net Income From Continuing Operations-13.70-12.56-13.67-15.58-18.92-7.05-0.59-0.51
Net Income-13.70-12.56-13.67-15.58-18.92-7.05-0.59-0.51
EPS (Recurring)-40.10-56.93-394.20-2,405.01-6,614.34-1,756.33-145.82-126.98
EPS (Basic, Before Extraordinaries)-47.46-59.52-394.20-2,405.01-6,614.33-1,756.33-145.82-126.98
EPS (Diluted)-47.46-59.52-394.20-2,405.01-6,614.33-1,756.33-145.82-126.98
EBITDA-11.52-11.48-13.11-15.30-18.44-6.35-0.54-0.53
Non-Operating Income (Expense)0.220.240.130.170.160.00-0.00-3E-05
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.151.693.854.142.900.380.020.03
Price To Sales Ratio0.711.780.700.9818.31---
Gross Margin66.8159.7952.2127.83-134.59-5.6058.3465.96
Operating Margin-228.03-304.59-420.08-537.12-2,709.84-4,043.01-1,223.85-994.49
Net Margin-257.85-318.36-417.24-532.14-2,737.63-4,410.76-1,335.41-950.00
Shares Outstanding0.330.310.090.010.000.000.000.00
Market Capitalization4.684.685.900.3917.7517.75--

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue1.281.381.481.170.560.730.770.89
Cost of Goods Sold Incl. D&A0.470.430.460.400.320.400.420.63
Gross Profit0.810.941.020.770.240.320.350.25
Selling, General and Administrative Excl. Other4.174.223.104.173.104.003.533.47
Research and Development0.770.660.530.430.500.690.570.66
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-3.35-3.28-2.09-3.39-2.86-3.68-3.17-3.21
Interest Expense0.850.180.000.000.000.000.000.00
Unusual Expense0.000.000.780.000.000.000.000.00
Net Income Before Taxes-4.05-3.48-2.83-3.34-2.77-3.62-3.09-3.18
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-4.05-3.48-2.83-3.34-2.77-3.62-3.09-3.18
Net Income From Continuing Operations-4.05-3.48-2.83-3.34-2.77-3.62-3.09-3.18
Net Income-4.05-3.48-2.83-3.34-2.77-3.62-3.09-3.18
EPS (Recurring)-12.35-10.80-8.20-14.17-12.77-35.18-34.42-127.07
EPS (Basic, Before Extraordinaries)-12.35-10.80-10.15-14.17-12.77-35.18-34.42-127.07
EPS (Diluted)-12.35-10.80-10.15-14.17-12.77-35.18-34.42-127.07
EBITDA-3.23-3.13-1.92-3.25-2.74-3.57-2.99-3.05
Non-Operating Income (Expense)0.16-0.020.030.050.090.060.090.03
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.410.330.340.060.420.870.880.91
Price To Sales Ratio0.711.782.363.012.522.311.801.12
Gross Margin63.6468.5368.6765.9043.4444.4945.8428.64
Operating Margin-262.24-237.85-140.92-289.17-506.56-506.47-412.08-362.46
Net Margin-316.65-252.07-191.22-284.65-490.96-498.07-400.91-358.96
Shares Outstanding0.330.320.310.250.220.220.090.09
Market Capitalization4.688.2010.3210.157.4216.015.9013.30

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments3.766.542.438.577.320.250.15
Short Term Receivables1.700.860.530.240.090.010.05
Inventories1.050.610.550.410.190.040.06
Other Current Assets0.260.210.380.120.070.000.00
Total Current Assets6.778.213.899.357.670.300.27
Net Property, Plant & Equipment1.051.151.611.671.180.000.00
Total Investments and Advances0.000.000.000.000.000.000.00
Intangible Assets2.890.000.000.000.000.000.00
Other Assets0.050.480.850.080.420.090.00
Total Assets10.769.846.3411.099.270.390.27
Short Term Debt Incl. Current Port. of LT Debt0.140.291.430.2313.060.190.73
Accounts Payable0.840.370.430.550.480.590.45
Other Current Liabilities2.231.211.281.751.730.720.51
Total Current Liabilities3.211.873.142.5315.271.491.69
Long Term Debt0.000.140.430.680.910.320.19
Provision for Risks Charges0.000.000.000.000.000.000.00
Other Liabilities2.511.862.001.620.000.010.00
Total Liabilities5.723.875.574.8416.191.831.88
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value3.073.750.000.0013.641.271.27
Common Equity1.972.220.786.25-20.55-4.42-3.88
Total Shareholders Equity5.045.970.786.25-6.91-3.14-2.61
Accumulated Minority Interest0.000.000.000.000.001.710.99
Total Equity5.045.970.786.25-6.91-1.44-1.61
Total Liabilities & Stockholders Equity10.769.846.3411.099.270.390.27
Book Value Per Share6.3424.7483.771,557.88-5,121.25-1,100.30-966.94
Tangible Book Value Per Share-2.9924.7483.771,557.88-5,121.25-1,100.30-966.94
Full-Time Employees262721229--
Price to Book Ratio-0.122.660.161.371.37--
Return on Assets-121.89-168.93-178.74-185.82-145.89-177.50-
Return on Equity-228.06-405.19-443.27----
Return on Invested Capital-249.13-223.71-1,291.96-272.78---
Quick Ratio1.784.071.063.530.490.170.12
Current Ratio2.114.391.243.690.500.200.16

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-13.70-12.56-13.67-15.58-18.92-7.08-0.71-0.59
Depreciation0.590.530.660.430.290.11--
Other Funds (Non Cash)2.111.713.894.144.882.220.180.08
Funds from Operations-11.00-10.32-9.13-11.01-13.75-4.74-0.52-0.50
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-0.77-0.43-0.75-1.171.720.450.350.27
Cash from Operating Activities-11.77-10.74-9.88-12.18-12.03-4.29-0.17-0.24
Capital Expenditures-1.06-1.02-0.19-0.36-0.85-0.100.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.006.50-2.04-4.400.000.00
Purchase of Investments0.000.000.00-0.49-10.12-4.40--
Sale Or Maturity of Investments0.000.000.007.008.080.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-1.06-1.02-0.196.14-2.88-4.500.000.00
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock1.928.9915.225.5614.11-0.290.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock1.928.9915.225.5614.11-0.290.000.00
Proceedsfrom Stock Options-0.93-0.9310.570.4914.11-0.290.000.00
Issuance or Reduction of Debt, Net4.300.000.001.250.0011.760.280.32
Change in Long Term Debt0.000.000.001.250.0011.760.280.32
Issuance of Long Term Debt0.000.000.001.250.0012.000.280.32
Reduction of Long Term Debt0.000.000.000.000.00-0.240.000.00
Net Financing Active Other Cash Flow0.430.00-1.10-0.510.000.00-0.020.00
Other Financing Activities Uses0.430.00-1.10-0.510.000.00-0.020.00
Cash from Financing Activities6.668.9914.126.3014.1111.470.250.32
Exchange Rate Effect-0.000.050.040.01-0.000.010.00
Net Change in Cash-6.17-2.784.110.30-0.792.670.090.09
Free Cash Flow-12.82-11.77-10.06-12.54-12.87-4.39-0.17-0.24
Preferred Dividends (Cash Flow)---0.000.00---
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments1.684.613.763.447.8510.31
Short Term Receivables1.951.971.701.310.770.89
Inventories0.780.811.051.360.690.61
Other Current Assets0.400.240.260.430.580.19
Total Current Assets4.817.626.776.549.8811.99
Net Property, Plant & Equipment2.202.291.050.861.111.03
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets2.862.882.892.910.000.00
Other Assets0.050.050.050.050.120.37
Total Assets9.9212.8410.7610.3711.1113.39
Short Term Debt Incl. Current Port. of LT Debt5.024.300.140.220.290.29
Accounts Payable0.630.650.840.620.890.50
Other Current Liabilities2.652.462.232.201.381.40
Total Current Liabilities8.307.413.213.042.562.19
Long Term Debt1.131.190.000.000.000.07
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities2.232.352.512.531.841.76
Total Liabilities11.6610.945.725.574.404.02
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value3.073.073.073.073.753.75
Common Equity-4.82-1.181.971.722.965.62
Total Shareholders Equity-1.741.905.044.806.719.38
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity-1.741.905.044.806.719.38
Total Liabilities & Stockholders Equity9.9212.8410.7610.3711.1113.39
Book Value Per Share-14.57-3.656.347.0113.6525.93
Tangible Book Value Per Share-23.22-12.57-2.99-4.8113.6525.93
Full-Time Employees--26---
Price to Book Ratio-0.12-6.955.255.892.512.85
Return on Assets-130.22-94.66-121.89-109.47-147.85-128.08
Return on Equity-551.19-220.32-228.06-197.26-335.48-210.97
Return on Invested Capital--112.82-56.19-69.59-41.25-38.30
Quick Ratio0.480.921.781.703.595.19
Current Ratio0.581.032.112.153.865.46

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-4.05-3.48-2.83-3.34-2.77-3.62
Depreciation0.130.150.160.140.110.11
Other Funds (Non Cash)1.130.560.360.060.420.87
Funds from Operations-2.80-2.76-2.31-3.14-2.24-2.64
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.04-0.200.08-0.690.020.15
Cash from Operating Activities-2.76-2.96-2.22-3.82-2.21-2.48
Capital Expenditures-0.17-0.06-0.940.11-0.190.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.75-0.750.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.17-0.06-0.19-0.64-0.190.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)---0.00--
Change in Capital Stock0.000.001.920.000.007.07
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.001.920.000.007.07
Proceedsfrom Stock Options0.000.00-0.930.000.000.00
Issuance or Reduction of Debt, Net0.004.300.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.00-0.430.810.06-0.06-0.81
Other Financing Activities Uses0.00-0.430.810.06-0.06-0.81
Cash from Financing Activities0.003.872.730.06-0.066.26
Exchange Rate Effect--0.000.000.000.00
Net Change in Cash-2.930.850.31-4.40-2.463.78
Free Cash Flow-2.93-3.02-3.17-3.71-2.41-2.48

Revenue breakdown

Surgical & Medical Instruments & Apparatus2024: 3.28M 2025: 3.94M
United States2024: 3.28M 2025: 3.94M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.85%0.1M2.5M6.34M
2026-10-152.11%0.1M2.5M6.32M
2026-09-306.75%0.1M0.9M6.30M
2026-09-1559.92%0.5M0.9M5.59M
2026-08-3115.31%0.1M0.9M1.34M
2026-08-141.46%0.0M0.6M219.49K
2026-07-311.73%0.0M0.4M201.72K
2026-07-153.73%0.0M0.4M203.01K
2026-06-3027.24%0.1M0.2M160.88K
2026-06-152.56%0.0M0.3M3.35K
2026-05-291.53%0.0M0.3M3.43K
2026-05-151.81%0.0M0.3M3.96K
2026-04-301.92%0.0M0.3M29.26K
2026-04-152.33%0.0M0.3M29.85K
2026-03-312.45%0.0M0.3M29.60K
2026-03-131.93%0.0M0.3M28.63K
2026-02-272.73%0.0M0.3M28.04K
2026-02-138.44%0.0M0.3M27.87K
2026-01-300.80%0.0M0.3M2.74K
2026-01-150.50%0.0M0.3M10.90K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-228-KCurrent report2026-10-16SEC
2026-10-16424B5SEC
2026-10-09EFFECTEffectiveness filing by commission orderSEC
2026-10-09424B3SEC
2026-10-093Initial statement of beneficial ownership of securities2026-10-01SEC
2026-10-05S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-09-21DNotice of sales of securities on Form D (Regulation D)SEC
2026-09-168-KCurrent report2026-09-11SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-08SEC
2026-09-098-KCurrent report2026-09-09SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-09-08424B3SEC
2026-09-04EFFECTEffectiveness filing by commission orderSEC
2026-09-04DNotice of sales of securities on Form D (Regulation D)SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-09-02S-3/ASEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-314Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-313Initial statement of beneficial ownership of securities2026-08-26SEC
2026-08-318-KCurrent report2026-08-27SEC
2026-08-268-K/A2026-03-11SEC
2026-08-248-KCurrent report2026-08-24SEC
2026-08-18EFFECTEffectiveness filing by commission orderSEC
2026-08-17S-3/ASEC
2026-08-14SCHEDULE 13GSEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-08-13DEL AMSeparately filed delaying amendment under Securities Act Rule 473 to delay effectiveness of a 1933 Act registration statementSEC
2026-08-11S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-09397.76K5546.26K4
2026-08102.46K159.41K3
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Warberg Asset Management LLC3.63%
ARMISTICE CAPITAL, LLC1.45%
HRT FINANCIAL LP0.71%
GEODE CAPITAL MANAGEMENT, LLC0.68%
VANGUARD CAPITAL MANAGEMENT LLC0.61%
SBI Securities Co., Ltd.0.43%
VANGUARD FIDUCIARY TRUST CO0.38%
NORTHERN TRUST CORP0.26%
Spectrum Asset Management, Inc. (NB/CA)0.09%
CITIGROUP INC0.01%

Funds

Fund% owned
VANGUARD EXTENDED MARKET INDEX FUND0.61%
Fidelity Extended Market Index Fund0.22%
Fidelity Series Total Market Index Fund0.05%
Fidelity Nasdaq Composite Index Fund0.01%
Blackstone Alternative Multi-Strategy Fund0.00%

OakChart. TNON. Cached 15 minutes.

Some panels did not load: ratings.